600216 Stock Overview
Manufactures and sells life nutrition and pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Zhejiang Medicine Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.94 |
| 52 Week High | CN¥17.50 |
| 52 Week Low | CN¥7.97 |
| Beta | 0.0096 |
| 11 Month Change | 3.18% |
| 3 Month Change | 55.30% |
| 1 Year Change | 35.20% |
| 33 Year Change | -19.24% |
| 5 Year Change | 17.36% |
| Change since IPO | 437.74% |
Recent News & Updates
Is Zhejiang Medicine (SHSE:600216) A Risky Investment?
Sep 14
What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You
Aug 06Recent updates
Is Zhejiang Medicine (SHSE:600216) A Risky Investment?
Sep 14What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You
Aug 06Zhejiang Medicine (SHSE:600216) Is Reducing Its Dividend To CN¥0.15
Jul 05The Market Doesn't Like What It Sees From Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Earnings Yet
Jun 21Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem
May 02Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet
Mar 29Shareholder Returns
| 600216 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.9% | -2.9% | -2.1% |
| 1Y | 35.2% | -17.4% | -21.1% |
Return vs Industry: 600216 exceeded the CN Pharmaceuticals industry which returned -15.2% over the past year.
Return vs Market: 600216 exceeded the CN Market which returned -20.6% over the past year.
Price Volatility
| 600216 volatility | |
|---|---|
| 600216 Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 600216's share price has been volatile over the past 3 months.
Volatility Over Time: 600216's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 6,227 | Chun Lei Lu | www.zmc.top |
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products.
Zhejiang Medicine Co., Ltd. Fundamentals Summary
| 600216 fundamental statistics | |
|---|---|
| Market cap | CN¥14.37b |
| Earnings (TTM) | CN¥472.71m |
| Revenue (TTM) | CN¥8.26b |
30.4x
P/E Ratio1.7x
P/S RatioIs 600216 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600216 income statement (TTM) | |
|---|---|
| Revenue | CN¥8.26b |
| Cost of Revenue | CN¥5.67b |
| Gross Profit | CN¥2.59b |
| Other Expenses | CN¥2.12b |
| Earnings | CN¥472.71m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.49 |
| Gross Margin | 31.34% |
| Net Profit Margin | 5.72% |
| Debt/Equity Ratio | 7.9% |
How did 600216 perform over the long term?
See historical performance and comparison